Patients with glaucoma who underwent cataract surgery in combination with the Omni surgical system had lower IOP and used fewer medications at 24 months compared with outcomes with other devices, according to a study.
Michael Mbagwu, MD, and colleagues conducted a retrospective study, published in the American Journal of Ophthalmology International, using real-world data from the IRIS Registry to explore three MIGS devices — Omni surgical system (Sight Sciences), Hydrus (Alcon) and iStent inject (Glaukos) — in combination with cataract surgery.
“Given the widespread